Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 120


68Ga-EDTA PET/CT imaging and plasma clearance for glomerular filtration rate quantification: comparison to conventional 51Cr-EDTA.

Hofman M, Binns D, Johnston V, Siva S, Thompson M, Eu P, Collins M, Hicks RJ.

J Nucl Med. 2015 Mar;56(3):405-9. doi: 10.2967/jnumed.114.147843. Epub 2015 Feb 12.


Seipin performs dissectible functions in promoting lipid droplet biogenesis and regulating droplet morphology.

Cartwright BR, Binns DD, Hilton CL, Han S, Gao Q, Goodman JM.

Mol Biol Cell. 2015 Feb 15;26(4):726-39. doi: 10.1091/mbc.E14-08-1303. Epub 2014 Dec 24.


Bifunctional (64)Cu-labelled macrobicyclic cage amine isothiocyanates for immuno-positron emission tomography.

Paterson BM, Buncic G, McInnes LE, Roselt P, Cullinane C, Binns DS, Jeffery CM, Price RI, Hicks RJ, Donnelly PS.

Dalton Trans. 2015 Mar 21;44(11):4901-9. doi: 10.1039/c4dt02983f.


Differential 18F-FDG and 18F-FLT Uptake on Serial PET/CT Imaging Before and During Definitive Chemoradiation for Non-Small Cell Lung Cancer.

Everitt SJ, Ball DL, Hicks RJ, Callahan J, Plumridge N, Collins M, Herschtal A, Binns D, Kron T, Schneider M, MacManus M.

J Nucl Med. 2014 May 15;55(7):1069-1074. [Epub ahead of print]


Correlation of p16 status, hypoxic imaging using [18F]-misonidazole positron emission tomography and outcome in patients with loco-regionally advanced head and neck cancer.

Trinkaus ME, Hicks RJ, Young RJ, Peters LJ, Solomon B, Bressel M, Corry J, Fisher R, Binns D, McArthur GA, Rischin D.

J Med Imaging Radiat Oncol. 2014 Feb;58(1):89-97. doi: 10.1111/1754-9485.12155.


Absence of a relationship between tumor ¹⁸F-fluorodeoxyglucose standardized uptake value and survival in patients treated with definitive radiotherapy for non-small-cell lung cancer.

Lin MY, Wu M, Brennan S, Campeau MP, Binns DS, MacManus M, Solomon B, Hicks RJ, Fisher RJ, Ball DL.

J Thorac Oncol. 2014 Mar;9(3):377-82. doi: 10.1097/JTO.0000000000000096.


In vivo measurement of hippocampal GABAA/cBZR density with [18F]-flumazenil PET for the study of disease progression in an animal model of temporal lobe epilepsy.

Vivash L, Gregoire MC, Bouilleret V, Berard A, Wimberley C, Binns D, Roselt P, Katsifis A, Myers DE, Hicks RJ, O'Brien TJ, Dedeurwaerdere S.

PLoS One. 2014 Jan 21;9(1):e86722. doi: 10.1371/journal.pone.0086722. eCollection 2014.


InterProScan 5: genome-scale protein function classification.

Jones P, Binns D, Chang HY, Fraser M, Li W, McAnulla C, McWilliam H, Maslen J, Mitchell A, Nuka G, Pesseat S, Quinn AF, Sangrador-Vegas A, Scheremetjew M, Yong SY, Lopez R, Hunter S.

Bioinformatics. 2014 May 1;30(9):1236-40. doi: 10.1093/bioinformatics/btu031. Epub 2014 Jan 21.


Preclinical FLT-PET and FDG-PET imaging of tumor response to the multi-targeted Aurora B kinase inhibitor, TAK-901.

Cullinane C, Waldeck KL, Binns D, Bogatyreva E, Bradley DP, de Jong R, McArthur GA, Hicks RJ.

Nucl Med Biol. 2014 Feb;41(2):148-54. doi: 10.1016/j.nucmedbio.2013.11.001. Epub 2013 Nov 15.


PET imaging of tumours with a 64Cu labeled macrobicyclic cage amine ligand tethered to Tyr3-octreotate.

Paterson BM, Roselt P, Denoyer D, Cullinane C, Binns D, Noonan W, Jeffery CM, Price RI, White JM, Hicks RJ, Donnelly PS.

Dalton Trans. 2014 Jan 21;43(3):1386-96. doi: 10.1039/c3dt52647j. Epub 2013 Nov 7.


High-resolution imaging of pulmonary ventilation and perfusion with 68Ga-VQ respiratory gated (4-D) PET/CT.

Callahan J, Hofman MS, Siva S, Kron T, Schneider ME, Binns D, Eu P, Hicks RJ.

Eur J Nucl Med Mol Imaging. 2014 Feb;41(2):343-9. doi: 10.1007/s00259-013-2607-4. Epub 2013 Nov 6.


Diagnostic imaging agents for Alzheimer's disease: copper radiopharmaceuticals that target Aβ plaques.

Hickey JL, Lim S, Hayne DJ, Paterson BM, White JM, Villemagne VL, Roselt P, Binns D, Cullinane C, Jeffery CM, Price RI, Barnham KJ, Donnelly PS.

J Am Chem Soc. 2013 Oct 30;135(43):16120-32. doi: 10.1021/ja4057807. Epub 2013 Oct 16.


Imaging of hypoxia with 18F-FAZA PET in patients with locally advanced non-small cell lung cancer treated with definitive chemoradiotherapy.

Trinkaus ME, Blum R, Rischin D, Callahan J, Bressel M, Segard T, Roselt P, Eu P, Binns D, MacManus MP, Ball D, Hicks RJ.

J Med Imaging Radiat Oncol. 2013 Aug;57(4):475-81. doi: 10.1111/1754-9485.12086. Epub 2013 Jun 14.


18F-flumazenil: a γ-aminobutyric acid A-specific PET radiotracer for the localization of drug-resistant temporal lobe epilepsy.

Vivash L, Gregoire MC, Lau EW, Ware RE, Binns D, Roselt P, Bouilleret V, Myers DE, Cook MJ, Hicks RJ, O'Brien TJ.

J Nucl Med. 2013 Aug;54(8):1270-7. doi: 10.2967/jnumed.112.107359. Epub 2013 Jul 15.


Validation of a 4D-PET maximum intensity projection for delineation of an internal target volume.

Callahan J, Kron T, Schneider-Kolsky M, Dunn L, Thompson M, Siva S, Aarons Y, Binns D, Hicks RJ.

Int J Radiat Oncol Biol Phys. 2013 Jul 15;86(4):749-54. doi: 10.1016/j.ijrobp.2013.02.030. Epub 2013 Apr 16.


The use of fused PET/CT images for patient selection and radical radiotherapy target volume definition in patients with non-small cell lung cancer: results of a prospective study with mature survival data.

Mac Manus MP, Everitt S, Bayne M, Ball D, Plumridge N, Binns D, Herschtal A, Cruickshank D, Bressel M, Hicks RJ.

Radiother Oncol. 2013 Mar;106(3):292-8. doi: 10.1016/j.radonc.2012.12.018. Epub 2013 Mar 28.


The impact of time between staging PET/CT and definitive chemo-radiation on target volumes and survival in patients with non-small cell lung cancer.

Everitt S, Plumridge N, Herschtal A, Bressel M, Ball D, Callahan J, Kron T, Schneider-Kolsky M, Binns D, Hicks RJ, Mac Manus M.

Radiother Oncol. 2013 Mar;106(3):288-91. doi: 10.1016/j.radonc.2013.02.010. Epub 2013 Mar 13.


Sex and SUVmax: sex-dependent prognostication in early non-small cell lung cancer.

Wainer Z, Daniels MG, Callahan J, Binns D, Hicks RJ, Antippa P, Russell PA, Alam NZ, Conron M, Solomon B, Wright GM.

J Nucl Med. 2012 Nov;53(11):1676-85. doi: 10.2967/jnumed.112.105197. Epub 2012 Sep 14.


Scatter limitation to correct for arm movement in PET/CT.

Callahan J, Binns D, Deller T, Hicks RJ.

Clin Nucl Med. 2012 Aug;37(8):786-7. doi: 10.1097/RLU.0b013e3182531cdf.


Hypometabolism precedes limbic atrophy and spontaneous recurrent seizures in a rat model of TLE.

Jupp B, Williams J, Binns D, Hicks RJ, Cardamone L, Jones N, Rees S, O'Brien TJ.

Epilepsia. 2012 Jul;53(7):1233-44. doi: 10.1111/j.1528-1167.2012.03525.x. Epub 2012 Jun 12.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk